DYN Butterfly Strategy
DYN (Dyne Therapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts..
DYN (Dyne Therapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $3.05B, a beta of 1.08 versus the broader market, a 52-week range of 8.06-25, average daily share volume of 2.1M, a public-listing history dating back to 2020, approximately 192 full-time employees. These structural characteristics shape how DYN stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.08 places DYN roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a butterfly on DYN?
A long call butterfly buys one lower-strike call, sells two ATM calls, and buys one higher-strike call, paying a small net debit for a defined-risk position that maxes out if the underlying pins the middle strike at expiration.
Current DYN snapshot
As of May 15, 2026, spot at $17.34, ATM IV 88.90%, IV rank 14.11%, expected move 25.49%. The butterfly on DYN below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this butterfly structure on DYN specifically: DYN IV at 88.90% is on the cheap side of its 1-year range, which favors premium-buying structures like a DYN butterfly, with a market-implied 1-standard-deviation move of approximately 25.49% (roughly $4.42 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated DYN expiries trade a higher absolute premium for lower per-day decay. Position sizing on DYN should anchor to the underlying notional of $17.34 per share and to the trader's directional view on DYN stock.
DYN butterfly setup
The DYN butterfly below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With DYN near $17.34, the first option leg uses a $16.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed DYN chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 DYN shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $16.00 | $2.85 |
| Sell 2 | Call | $17.50 | $1.53 |
| Buy 1 | Call | $17.50 | $1.53 |
DYN butterfly risk and reward
- Net Premium / Debit
- -$132.50
- Max Profit (per contract)
- $17.50
- Max Loss (per contract)
- -$132.50
- Breakeven(s)
- $17.33
- Risk / Reward Ratio
- 0.132
Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit.
DYN butterfly payoff curve
Modeled P&L at expiration across a range of underlying prices for the butterfly on DYN. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -99.9% | -$132.50 |
| $3.84 | -77.8% | -$132.50 |
| $7.68 | -55.7% | -$132.50 |
| $11.51 | -33.6% | -$132.50 |
| $15.34 | -11.5% | -$132.50 |
| $19.17 | +10.6% | +$17.50 |
| $23.01 | +32.7% | +$17.50 |
| $26.84 | +54.8% | +$17.50 |
| $30.67 | +76.9% | +$17.50 |
| $34.51 | +99.0% | +$17.50 |
When traders use butterfly on DYN
Butterflies on DYN are pinning bets - traders use them when they expect DYN to settle near a specific level at expiration (often the prior close, a round number, or the max-pain strike) and want defined-risk exposure to that outcome.
DYN thesis for this butterfly
The market-implied 1-standard-deviation range for DYN extends from approximately $12.92 on the downside to $21.76 on the upside. A DYN long call butterfly is a pinning play: it pays maximum at the middle strike if DYN settles there at expiration, with the wing legs capping both the cost and the maximum loss to the net debit. Current DYN IV rank near 14.11% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on DYN at 88.90%. As a Healthcare name, DYN options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to DYN-specific events.
DYN butterfly positions are structurally neutral / pin (limited-risk, limited-reward); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. DYN positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move DYN alongside the broader basket even when DYN-specific fundamentals are unchanged. Always rebuild the position from current DYN chain quotes before placing a trade.
Frequently asked questions
- What is a butterfly on DYN?
- A butterfly on DYN is the butterfly strategy applied to DYN (stock). The strategy is structurally neutral / pin (limited-risk, limited-reward): A long call butterfly buys one lower-strike call, sells two ATM calls, and buys one higher-strike call, paying a small net debit for a defined-risk position that maxes out if the underlying pins the middle strike at expiration. With DYN stock trading near $17.34, the strikes shown on this page are snapped to the nearest listed DYN chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are DYN butterfly max profit and max loss calculated?
- Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit. For the DYN butterfly priced from the end-of-day chain at a 30-day expiry (ATM IV 88.90%), the computed maximum profit is $17.50 per contract and the computed maximum loss is -$132.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a DYN butterfly?
- The breakeven for the DYN butterfly priced on this page is roughly $17.33 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current DYN market-implied 1-standard-deviation expected move is approximately 25.49%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a butterfly on DYN?
- Butterflies on DYN are pinning bets - traders use them when they expect DYN to settle near a specific level at expiration (often the prior close, a round number, or the max-pain strike) and want defined-risk exposure to that outcome.
- How does current DYN implied volatility affect this butterfly?
- DYN ATM IV is at 88.90% with IV rank near 14.11%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.